512036 SKYBIOTECH

Skybiotech Healthcare Share Price

 

 

Start SIP in SKYBIOTECH

Start SIP
Skybiotech Healthcare live price: ₹163.8. It opened at ₹164 vs previous close ₹157; intraday high/low: ₹164/₹164. The 50 & 200 DMA stand at ₹152.44/₹174.60.

Skybiotech Healthcare Performance

  • Today's Low
  • ₹164
  • Today's High
  • ₹164
  • 52 Week Low
  • ₹116
  • 52 Week High
  • ₹237
  • Open Price₹164
  • Previous Close₹157
  • Volume1
  • 50 DMA₹152.44
  • 100 DMA₹164.45
  • 200 DMA₹174.60

Investment Returns

  • Over 1 Month + 25.18%
  • Over 3 Month -12.15%
  • Over 6 Month + 0.92%
  • Over 1 Year -2.03%

Smart Investing Starts Here Start SIP with Skybiotech Healthcare for Steady Growth!

Invest Now

Skybiotech Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -16.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 31
  • P/B Ratio
  • 3.8
  • Average True Range
  • 6.34
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.19
  • RSI
  • 61.52
  • MFI
  • 62.72

Skybiotech Healthcare Financials

Skybiotech Healthcare Technicals

EMA & SMA

Current Price
₹163.80
+ 6.9 (4.4%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹146.24
  • 50 Day
  • ₹152.44
  • 100 Day
  • ₹164.45
  • 200 Day
  • ₹174.60

Resistance and Support

163.8 Pivot Speed
  • R3 163.80
  • R2 163.80
  • R1 163.80
  • S1 163.80
  • S2 163.80
  • S3 163.80

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Skybiotech Healthcare Ltd has an operating revenue of Rs. 6.29 Cr. on a trailing 12-month basis. An annual revenue de-growth of -91% needs improvement, Pre-tax margin of -34% needs improvement, ROE of -26% is poor and needs improvement. The company has a debt to equity of 78%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 118 indicates it belongs to a poor industry group of Apparel-Clothing Mfg and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Skybiotech Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-28 Increase in Authorised Capital
2025-08-14 Quarterly Results
2025-05-30 Audited Results

Skybiotech Healthcare F&O

Skybiotech Healthcare Shareholding Pattern

63.48%
34.88%
1.64%

Skybiotech Healthcare FAQs

Skybiotech Healthcare share price is ₹163 As on 19 March, 2026 | 19:23

The Market Cap of Skybiotech Healthcare is ₹31.4 Cr As on 19 March, 2026 | 19:23

The P/E ratio of Skybiotech Healthcare is -16.5 As on 19 March, 2026 | 19:23

The PB ratio of Skybiotech Healthcare is 3.8 As on 19 March, 2026 | 19:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23